Research institute for biological safety problems
On June 22, 2021, Kazakhstan’s second COVID-19 vaccine QazCoVac-P (subunit) was officially included in the list of candidate vaccines of the World Health Organization for conducting phase 1/2 clinical trials.…
On June 19, 2021, in Nur-Sultan, an award ceremony for the best doctors of Kazakhstan, the winners of the competition “Our dear doctor! Our Hero!”, dedicated to the Day of…
On the day of the medical worker, the Minister of Health of the Republic of Kazakhstan Alexey Vladimirovich Tsoi presented a departmental award: a badge “For contribution to healthcare” to…
On June 15, 2021, clinical studies of COVID-19 domestic subunit vaccine with the involvement of volunteers from 18 to 50 years old in Taraz city multi-field hospital have begun. RSE…
On May 28, 2021, the Chairwoman of the World Health Organization (WHO) in Kazakhstan, Caroline Clarinval, met with the Director General of the Research Institute for Biological Safety Problems. During…
President of the Republic of Kazakhstan Kassym-Jomart Tokayev held a meeting with Director-General of the World Health Organization Dr. Tedros Adhanom Ghebreyesus via videoconference. During the talks, the sides discussed…
According to the results of the annual contest «Best Engineer of the Year”, where independent experts and organizations are nominated, where the most advanced engineer-specialists, innovators of creative ideas who…
The domestic inactivated vaccine Qazvac against COVID-19, developed by the Research Institute of Biological Safety Problems of the Ministry of Education and Science of the Republic of Kazakhstan, is now…
The creation of a Kazakh vaccine against COVID-19 by the Research Institute of Biological Safety Problems of the Ministry of Education and Science of the Republic of Kazakhstan has become…
On May 22, 2021, State Inspector of the Presidential Administration of the Republic of Kazakhstan Ospankulov Gabidulla Abdullaevich paid a working visit to the RSE «Research Institute for Biological Safety…